[{"orgOrder":0,"company":"Vakzine Projekt Management","sponsor":"Serum Institute of India","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Vaccine","year":"2020","type":"Inapplicable","leadProduct":"VPM1002","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Vakzine Projekt Management","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Vakzine Projekt Management \/ Vakzine Projekt Management","highestDevelopmentStatusID":"10","companyTruncated":"Vakzine Projekt Management \/ Vakzine Projekt Management"},{"orgOrder":0,"company":"Vakzine Projekt Management","sponsor":"FGK Clinical Research","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"GERMANY","productType":"Vaccine","year":"2020","type":"Inapplicable","leadProduct":"VPM1002","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Vakzine Projekt Management","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Vakzine Projekt Management \/ FGK Clinical Research","highestDevelopmentStatusID":"10","companyTruncated":"Vakzine Projekt Management \/ FGK Clinical Research"},{"orgOrder":0,"company":"Vakzine Projekt Management","sponsor":"FGK Clinical Research","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"GERMANY","productType":"Vaccine","year":"2020","type":"Inapplicable","leadProduct":"VPM1002","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Vakzine Projekt Management","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Vakzine Projekt Management \/ FGK Clinical Research","highestDevelopmentStatusID":"10","companyTruncated":"Vakzine Projekt Management \/ FGK Clinical Research"}]

Find Clinical Drug Pipeline Developments & Deals by Vakzine Projekt Management

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : VPM1002 is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Respiratory Tract Infections.

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          June 17, 2020

                          Lead Product(s) : VPM1002

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : FGK Clinical Research

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : VPM1002 is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Respiratory Tract Infections.

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          May 13, 2020

                          Lead Product(s) : VPM1002

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : FGK Clinical Research

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : VPM1002 is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tuberculosis.

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          April 17, 2020

                          Lead Product(s) : VPM1002

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Recipient : Serum Institute of India

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank